Creatine and Perioperative Brain Health

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-85
SponsorMassachusetts General Hospital

About this trial

The overall goal of this study is to evaluate the feasibility of perioperative oral creatine supplementation and to explore its effects on cognitive function and physiological responses to surgery in older adults. Creatine is commonly used to enhance athletic performance, but it can also have positive effects on the brain. Since surgery can alter thinking, memory, and attention patterns in some patients, we will assess whether creatine affects these changes in older adults undergoing surgery.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients scheduled for elective surgery under general anesthesia

Disqualifiers

History of creatine deficiency disorders

Renal or neurodegenerative disorders

History of stroke or significant head trauma, presence of intracranial mass lesions

Inability to give informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Creatine monohydrate

    Dietary supplement

    Participants will receive creatine supplementation before surgery

  • Placebo

    Other intervention

    Participants in the placebo group will receive an identical placebo before surgery

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Creatine groupExperimental treatment 1 intervention
Group B: Placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Preoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within three weeks before surgery
2

Postoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within one month after surgery
3

Postoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within three months after surgery
4

Postoperative delirium assessed with the Confusion Assessment Method (CAM)

The CAM is a validated tool to detect postoperative delirium

Time frame
Up to 7 days after surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: